Avascular Necrosis Market
- 2026 年市場規模
- USD 809.5 Mn
- 2033 年預估規模
- USD 1,216.9 Mn
- 年複合成長率 CAGR
- 6%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Avascular Necrosis Market, By Drug Type (Nonsteroidal anti-inflammatory drugs (Ibuprofen, Naproxen Sodium), Osteoporosis drugs, Cholesterol-lowering drugs, Blood thinners, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Avascular necrosis is a disease that results from the short-term or permanent loss of blood supply to the bone. This cut-off of blood supply to bone leads to tiny breaks in the bone and the bones eventually collapse. Avascular necrosis is also known as osteonecrosis. This condition may happen in any bone of the body, but mostly happens in the ends of a long bone. A broken bone or dislocated joint can interrupt the blood flow to a section of bone. Avascular necrosis condition is most common in people between the ages of 30 and 50.
Avascular necrosis can be caused due to-
• Injury to bone
• Fracture
• Damage of blood vessels
• Long-term use of medicines, such as corticosteroids
• Excessive, long-term use of alcohol
Avascular necrosis can be diagnosed by Bone scan, Magnetic Resonance Image and Computed Tomography, and X-rays. Medications used to treat avascular necrosis are blood thinners, nonsteroidal anti-inflammatory drugs, cholesterol lowering drugs and others.
Market Dynamics
Increasing number of product launches is expected to drive the growth of global avascular necrosis market during the forecast period. For instance, in September 2014, Bayer Healthcare LLC, a pharmaceutical and medicine manufacturing company, announced the launch of Aleve PM, an over-the-counter (OTC) pain reliever product in the U.S.
Increasing number of drug approvals from regulatory bodies is expected to drive the growth of the global avascular necrosis market. For instance, in April 2019, the U.S Food and Drugs Administration approved Evenity (romosozumab-aqqg), a sclerostin inhibitor indicated to treat osteoporosis in postmenopausal women at high risk of breaking a bone.
Key features of the study
• This report provides an in-depth analysis of the global avascular necrosis market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global avascular necrosis market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Solara Active Pharma Sciences Limited., Bayer AG, Rochem International, Inc., Alkem Labs., Dwarkesh Pharmaceuticals Private Limited., Novartis AG, GSK, and Pfizer Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global avascular necrosis market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global avascular necrosis market
Market Segmentation
• By Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
o Nonsteroidal anti-inflammatory drugs (Ibuprofen, Naproxen Sodium)
o Osteoporosis Drugs
o Cholesterol-lowering Drugs
o Blood Thinners
o Others
• By Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
o Oral
o Injectable
• By Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
North Africa
South Africa
Central Africa
• Key Players in the Avascular Necrosis Market
o Teva Pharmaceutical Industries Ltd.
o Reddy’s Laboratories Ltd.
o Solara Active Pharma Sciences Limited
o Bayer AG
o Rochem International Inc.
o Alkem labs.
o Dwarkesh Pharmaceuticals Private Limited.
o Novartis AG
o GSK
o Pfizer, Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Distribution Channel
Market Snippet, By Route of Administration
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Market Trends
o Recent Product Launches/Approvals
o Regulatory Scenario
o Epidemiology
o PEST Analysis
o Acquisition and Collaboration Scenario
4. Global Avascular Necrosis Market, By Drug Type, 2021 – 2033 (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Nonsteroidal anti-inflammatory drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
o Ibuprofen
o Naproxen Sodium
o Osteoporosis drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
o Cholesterol-lowering drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
o Blood Thinners
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
5. Global Avascular Necrosis Market, By Route of Administration, 2021 – 2033 (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
o Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
6. Global Avascular Necrosis Market, By Distribution Channel, 2021 – 2033, (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Million)
7. Global Avascular Necrosis Market, By Region, 2021 – 2033, (USD Million)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, By Region, 2022 – 2033
Regional Trends
o North America
Market Size and Forecast, By Drug Type, 2021 – 2033, (USD Million)
Market Size and Forecast, By Route of Administration 2021 – 2033, (USD Million)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Million)
Market Size and Forecast, By Country, 2021 – 2033, (USD Million)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Drug Type, 2021 – 2033, (USD Million)
Market Size and Forecast, By Route of Administration 2021 – 2033, (USD Million)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Million)
Market Size and Forecast, By Country, 2021 – 2033, (USD Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Drug Type, 2021 – 2033, (USD Million)
Market Size and Forecast, By Route of Administration 2021 – 2033, (USD Million)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Million)
Market Size and Forecast, By Country, 2021 – 2033, (USD Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of APAC
o Latin America
Market Size and Forecast, By Drug Type, 2021 – 2033, (USD Million)
Market Size and Forecast, By Route of Administration 2021 – 2033, (USD Million)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Million)
Market Size and Forecast, By Country, 2021 – 2033, (USD Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Middle East
Market Size and Forecast, By Drug Type, 2021 – 2033, (USD Million)
Market Size and Forecast, By Route of Administration 2021 – 2033, (USD Million)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Million)
Market Size and Forecast, By Country, 2021 – 2033, (USD Million)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Drug Type, 2021 – 2033, (USD Million)
Market Size and Forecast, By Route of Administration 2021 – 2033, (USD Million)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Million)
Market Size and Forecast, By Country, 2021 – 2033, (USD Million)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Company Profiles
Teva Pharmaceuticals Industries Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Dr. Reddy’s Laboratories Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Solara Active Pharma Sciences Limited.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Bayer AG
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Rochem International, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Alkem Labs.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Dwarkesh Pharmaceuticals Private Limited
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Novartis AG
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
GSK
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Pfizer, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們